CONTI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 6.724
EU - Europa 3.168
AS - Asia 1.137
SA - Sud America 25
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 4
OC - Oceania 4
Totale 11.076
Nazione #
US - Stati Uniti d'America 6.597
DE - Germania 676
IT - Italia 671
CN - Cina 449
SE - Svezia 365
IE - Irlanda 359
SG - Singapore 355
RU - Federazione Russa 282
UA - Ucraina 207
GB - Regno Unito 202
CA - Canada 125
AT - Austria 122
HK - Hong Kong 115
FI - Finlandia 98
IN - India 70
DK - Danimarca 62
TR - Turchia 54
FR - Francia 39
VN - Vietnam 38
BE - Belgio 36
KR - Corea 17
BR - Brasile 16
ID - Indonesia 15
CZ - Repubblica Ceca 13
EU - Europa 13
NL - Olanda 12
IR - Iran 10
JP - Giappone 8
CH - Svizzera 6
AU - Australia 4
PE - Perù 4
RO - Romania 4
CL - Cile 3
ES - Italia 3
EG - Egitto 2
NO - Norvegia 2
PL - Polonia 2
PT - Portogallo 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
GR - Grecia 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MA - Marocco 1
MC - Monaco 1
MX - Messico 1
PA - Panama 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 11.076
Città #
Ann Arbor 2.175
Chandler 534
Woodbridge 522
Frankfurt am Main 425
Wilmington 375
Dublin 348
Houston 328
Fairfield 298
Singapore 277
Jacksonville 265
Ashburn 257
Dearborn 250
Milan 221
New York 153
Seattle 134
Princeton 130
Vienna 122
Hong Kong 114
Cambridge 106
Santa Clara 104
Nanjing 95
Shanghai 75
Boardman 54
Lachine 51
Helsinki 36
Lawrence 36
Brussels 35
Nanchang 33
Beijing 32
Dong Ket 30
Ottawa 30
Guangzhou 27
Pune 24
Rome 24
Shenyang 23
Fremont 22
Altamura 21
San Diego 20
Tianjin 19
Andover 18
Falls Church 18
Toronto 18
Carate Brianza 17
Munich 16
Norwalk 16
Jakarta 15
Jiaxing 15
Dallas 14
Edmonton 14
Hebei 14
London 14
Monza 13
Brno 12
Changsha 12
Como 12
Jinan 12
Ningbo 12
Kunming 11
Los Angeles 11
Mountain View 11
Zhengzhou 11
Leawood 10
Lissone 10
Detroit 9
Monmouth Junction 9
Chicago 8
Lappeenranta 8
Taizhou 8
São Paulo 7
Gaziantep 6
Hangzhou 6
Hefei 6
Lecco 6
Pisa 6
Rozzano 6
Vadodara 6
Bergamo 5
Bielefeld 5
Bonn 5
Busto Arsizio 5
Daejeon 5
Grafing 5
Nürnberg 5
Redmond 5
Rho 5
Ripalta Cremasca 5
Verona 5
Bologna 4
Desio 4
Fuzhou 4
Haikou 4
Huizen 4
Lima 4
Melegnano 4
Misinto 4
Napoli 4
San Mateo 4
Verdellino 4
Washington 4
Auburn Hills 3
Totale 8.348
Nome #
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 397
QT interval and dispersion in drug-free anorexia nervosa adolescents: a case control study 347
QTc dispersion and interval changes in drug-free borderline personality disorder adolescents 346
Paradoxical Increase of plasma vitamin B12 and folates with disease severity in anorexia nervosa 293
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 285
Decreased whole-blood global DNA methylation is related to serum hormones in anorexia nervosa adolescents. 281
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 280
Irisin and BDNF serum levels and behavioral disturbances in Alzheimer's disease 262
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 260
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 253
Anorexia nervosa in adolescent girls and celiac disease serology 244
Serum DBI and biomarkers of neuroinflammation in Alzheimer's disease and delirium 243
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 241
Can Signaling Molecules in Fibroblasts Detect Prodromal Alzheimer's Disease? 241
The one-carbon metabolism in anorexia nervosa of the restrictive type 234
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 229
Beta-amyloid-induced peripheral chemotactic response: what role in Alzheimer’s disease? 222
Donepezil modulates the endogenous immune response: implications for Alzheimer's disease 209
Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy 201
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 199
Diazepam binding inhibitor and dehydroepiandrosterone sulphate plasma levels in borderline personality disorder adolescents. 196
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 188
Modulation of mapk phosphorylation in fibroblasts from alzheimer patients: erk involvment in glutamate transport and tau hyperphosporylation 179
Behavioural anomalies in neurodegenerative diseases: role of the immune response 175
Reduced fasting plasma levels of diazepam-binding inhibitor in adolescents with anorexia nervosa. 174
Lipid-based nanoparticles as a potential tool to reduce abeta toxic effect in a human cellular model 166
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 165
Anorexia nervosa of the restrictive type and celiac disease in adolescence 164
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 163
Increased Soluble APPalpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients 160
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 160
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 159
Beta-amyloid plasma levels in adolescents with anorexia nervosa of the restrictive type 157
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 156
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients 154
Modulation of mapk phosphorylation in fibroblasts from alzheimer’s patients: the erk involvment in ad severity and eaat1 expression 151
Longitudinal effects on plasma abeta levels of imatinib, a gamma-secretase activating protein inhibitor 149
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report 147
MAPK phosphorylation in fibroblasts from Alzheimer's disease patients: ERK involvement in EAAT1 expression and modulation with disease severity 147
Plasma anti-amyloid-β autoantibodies in all Alzheimer disease types 146
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 143
Affective states and pathology in adolescents with borderline personality 134
Role of donepezil in influencing endogenous immune response against abeta, an ex vivo and in vitro study 134
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 133
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 133
CLEARANCE OF BETA-AMYLOID OLIGOMERS BY PERIPHERAL MONOCYTES: FURTHER OBSERVATIONS REGARDING THE MODULATORY ROLE OF DONEPEZIL 131
the MonzALS collaborative network 128
Erk signalling modulates app metabolism, tau phosphorylation and eaat1 processing in fibroblasts from alzheimer’s patients 128
BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis 123
New insights into the genetic etiology of Alzheimer's disease and related dementias 122
Behavioural Anomalies in Neurodegenerative Diseases: Role of the Immune Response 121
Novel therapeutic targets in neuropsychiatric disorders: the neuroepigenome 120
Acetyl-Cholinesterase Inhibitors Modulate The Autoimmune Response Against Beta-Amyloid 117
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 114
Whole-blood global DNA methylation and phenotypic variability in ALS 113
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 106
Serum BDNF in amyotrophic lateral sclerosis decreases with disease severity 104
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 99
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 99
Nilotinib or Dasatinib, but not Imatinib, might reduce Plasma Beta-Amyloid in Leukemia Patients : Implications gor Alzheimer’s Disease 99
Donepezil modulates the endogenous immune response in Alzheimer’s disease, an ex vivo and in vitro study 98
Further ex vivo evidence for a role of donepezil in the modulation of the immune response 98
Blood-based biomarkers of neuroinflammation in alzheimer’s disease: A central role for periphery? 97
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 95
Immune response against beta-amyloid is modulated by acetyl-cholinesterase inhibitors 91
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 90
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 73
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 68
Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer’s Disease Patients 46
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 38
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 34
Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review 28
Totale 11.780
Categoria #
all - tutte 35.871
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.871


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.240 0 0 0 0 154 216 298 113 144 140 152 23
2020/20211.970 127 82 204 248 186 162 201 148 166 178 102 166
2021/20221.111 139 145 124 110 71 67 55 50 48 61 85 156
2022/20231.924 192 525 218 207 131 281 36 108 129 25 44 28
2023/20241.311 62 60 71 66 161 323 233 46 59 23 18 189
2024/2025977 171 277 212 113 204 0 0 0 0 0 0 0
Totale 11.780